AU3031800A - Foamy virus vectors for expressing foreign genes in mammals and the use thereof - Google Patents

Foamy virus vectors for expressing foreign genes in mammals and the use thereof

Info

Publication number
AU3031800A
AU3031800A AU30318/00A AU3031800A AU3031800A AU 3031800 A AU3031800 A AU 3031800A AU 30318/00 A AU30318/00 A AU 30318/00A AU 3031800 A AU3031800 A AU 3031800A AU 3031800 A AU3031800 A AU 3031800A
Authority
AU
Australia
Prior art keywords
des
immundefizienzvirus
felinen
mammals
foreign genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30318/00A
Inventor
Robert Flower
Rolf-M. Flugel
Martin Lochelt
Ingrid Winkler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of AU3031800A publication Critical patent/AU3031800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Beschrieben werden retrovirale, auf felinen Foamyviren (FeFV) basierende Vektoren zur Einführung einer gewünschten, exprimierbaren DNA in eine Säugerzelle. Ein Beispiel des erfindungsgemässen Vektors ist ein Vektor, der die Expression von neutralisierenden Epitopen des felinen Immundefizienzvirus (FIV) in der Katze oder des menschlichen Immundefizienzvirus (HIV) im Menschen und damit eine wirksame Vakzinierung erlaubt.
AU30318/00A 1998-12-17 1999-12-17 Foamy virus vectors for expressing foreign genes in mammals and the use thereof Abandoned AU3031800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19858441A DE19858441C2 (en) 1998-12-17 1998-12-17 FV vectors for the expression of foreign genes in mammals and their use
DE19858441 1998-12-17
PCT/DE1999/004052 WO2000036130A1 (en) 1998-12-17 1999-12-17 Foamy virus vectors for expressing foreign genes in mammals and the use thereof

Publications (1)

Publication Number Publication Date
AU3031800A true AU3031800A (en) 2000-07-03

Family

ID=7891539

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30318/00A Abandoned AU3031800A (en) 1998-12-17 1999-12-17 Foamy virus vectors for expressing foreign genes in mammals and the use thereof

Country Status (5)

Country Link
EP (1) EP1149171B1 (en)
AT (1) ATE321144T1 (en)
AU (1) AU3031800A (en)
DE (2) DE19858441C2 (en)
WO (1) WO2000036130A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002153275A (en) * 2000-11-17 2002-05-28 Katakura Industries Co Ltd Supuma virinae plasmid and its use
WO2015028683A1 (en) * 2013-09-02 2015-03-05 Cellectis Rna based method to obtain stably integrated retroviral vectors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4318387A1 (en) * 1993-06-03 1994-12-08 Bayer Ag Recombinant Foamy Virus vectors for medical and diagnostic applications and methods for producing recombinant Foamy Virus vectors
US5882912A (en) * 1997-02-12 1999-03-16 Center For Disease Control And Prevention Retrovirus isolated from humans

Also Published As

Publication number Publication date
ATE321144T1 (en) 2006-04-15
WO2000036130A1 (en) 2000-06-22
EP1149171B1 (en) 2006-03-22
DE59913264D1 (en) 2006-05-11
EP1149171A1 (en) 2001-10-31
DE19858441A1 (en) 2000-06-21
DE19858441C2 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
AU8154694A (en) Methods of increasing TGF-13 in the brain, inhibiting Alzeheimers disease and inhibiting B-amyloid peptide mediated neurotoxicity.
PL308122A1 (en) Viral vectors and their application in genic therapy
WO2000054813A3 (en) Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
EP0484374A4 (en) Rapid, versatile and simple system for expressing genes in eukaryotic cells
WO2002024234A3 (en) Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
MXPA02007478A (en) Human immunodeficiency virus vaccine.
IT1269313B (en) STABILIZING SYSTEM FOR LOW COLOR PROCESSING, STABILIZING AGAINST HEAT AND LIGHT FOR POLYPROPYLENE FIBER.
TW224968B (en)
IL108719A0 (en) Expression constructs containing hiv inhibitory antisense and other nucleotide sequences, retroviralvectors and recombinant retroviruses containing them
AU3262797A (en) Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
AU3031800A (en) Foamy virus vectors for expressing foreign genes in mammals and the use thereof
DE69330778D1 (en) BIRD-MYCOPLASMAANTIGEN, ITS GENE, THE GENE-CONTAINING RECOMBINANT VECTOR, AND THE VACCINE PRODUCED WITH IT
EP0623630A3 (en) Water-in-oil polymer emulsions, process for their preparation and their use.
NO903801D0 (en) ALKALIPULLUNASE, MICROORGANISM AND PROCEDURES IN THE PREPARATION OF IT.
Warnecke Burial societies, African religion and the Church.
Harding Social Policy and Social Justice
Lannon et al. The role of presidents promoting Catholic identity at Jesuit universities
Kaiser Advisers champion applied research.
Landis et al. The Downsized Economy: Employment and Establishment Trends in Oakland, 1981-1986
O'Neill Biggest stories of 1996.
Miller The parable of the stripper.
Dube Samaya Aur Sanskriti
邓飞其 et al. Characteristic Matrices and Similarity of Time-Varying Linear Differential Systems
Barth Mortal Beauty: Jesuit Tradition and the Arts
Mullins The teaching of" Lumen gentium" on the Holy Spirit: The Holy Spirit was sent at Pentecost in order that he might continually sanctify the Church

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase